Diversity of Retinal Vascular Anomalies in Patients with Familial Exudative Vitreoretinopathy
To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 121; no. 11; pp. 2220 - 2227 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.
Retrospective case series at a single tertiary referral vitreoretinal practice.
A total of 174 eyes of 87 subjects were studied.
A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.
Clinical and angiographic findings.
A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.
Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR. |
---|---|
AbstractList | To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.
Retrospective case series at a single tertiary referral vitreoretinal practice.
A total of 174 eyes of 87 subjects were studied.
A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.
Clinical and angiographic findings.
A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.
Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR. To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects were studied. A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Clinical and angiographic findings. A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR. To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.PURPOSETo describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.Retrospective case series at a single tertiary referral vitreoretinal practice.DESIGNRetrospective case series at a single tertiary referral vitreoretinal practice.A total of 174 eyes of 87 subjects were studied.PARTICIPANTSA total of 174 eyes of 87 subjects were studied.A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.METHODSA retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.Clinical and angiographic findings.MAIN OUTCOME MEASURESClinical and angiographic findings.A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.RESULTSA total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.CONCLUSIONSFamilial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR. Purpose To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Design Retrospective case series at a single tertiary referral vitreoretinal practice. Participants A total of 174 eyes of 87 subjects were studied. Methods A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Main Outcome Measures Clinical and angiographic findings. Results A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Conclusions Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR. |
Author | Trese, Michael T. Drenser, Kimberly A. Capone, Antonio Kashani, Amir H. Brown, Kevin T. Chang, Emmanuel |
Author_xml | – sequence: 1 givenname: Amir H. surname: Kashani fullname: Kashani, Amir H. organization: Department of Ophthalmology, University of Southern California, Los Angeles, California – sequence: 2 givenname: Kevin T. surname: Brown fullname: Brown, Kevin T. organization: School of Medicine, Wayne State University, Detroit, Michigan – sequence: 3 givenname: Emmanuel surname: Chang fullname: Chang, Emmanuel organization: Retina and Vitreous of Texas, Houston, Texas – sequence: 4 givenname: Kimberly A. surname: Drenser fullname: Drenser, Kimberly A. organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan – sequence: 5 givenname: Antonio surname: Capone fullname: Capone, Antonio organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan – sequence: 6 givenname: Michael T. surname: Trese fullname: Trese, Michael T. email: mgjt46@aol.com organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25005911$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl1rFDEUhoNU7Lb6D0Tm0puZnmQymRkRodS2CoWKH8UbCZnsGTZrZrImmW3335thqxdCKV6FJM_7Bp6cI3IwuhEJeUmhoEDFybpwm1VcqYIB5QVUBbD2CVnQirc5r2l5QBYJo7ngDA7JUQhrABCi5M_IIasAqpbSBfnx3mzRBxN3meuzzxjNqGx2o4KerPLZ6egGZQ2GzIzZJxUNjjFktyausgs1GGsSfH43LdPNFrMbEz06P5e4jYqr3XPytFc24Iv79Zh8uzj_evYhv7q-_Hh2epVrXkPMGYWyr0WlVVlC3XS16LseBG9AM2hVVyHrNJSs6gVNB2nPG9qzhoFo-rLh5TF5ve_dePdrwhDlYIJGa9WIbgqSCta2gvO6Seire3TqBlzKjTeD8jv5R0kC-B7Q3oXgsf-LUJCzebmWe_NyNi-hksl8ir35J6ZNTFrcGL0y9rHwu30Yk6StQS-DTqo1Lo1HHeXSmf8t0NaMRiv7E3cY1m7y6V-TCBmYBPllnox5MCgH4G35PRW8fbjg8fd_Azpgyik |
CitedBy_id | crossref_primary_10_1097_IAE_0000000000002490 crossref_primary_10_1186_s12886_023_02884_7 crossref_primary_10_1038_s41572_024_00501_5 crossref_primary_10_1016_j_exer_2019_107720 crossref_primary_10_1186_s12886_023_03243_2 crossref_primary_10_3928_01913913_20210720_01 crossref_primary_10_1016_j_celrep_2017_06_004 crossref_primary_10_1155_2017_3080245 crossref_primary_10_1155_2020_7681926 crossref_primary_10_1371_journal_pone_0149176 crossref_primary_10_1177_2474126417705256 crossref_primary_10_3928_23258160_20240410_02 crossref_primary_10_4103_ijo_IJO_1403_20 crossref_primary_10_1167_iovs_66_2_9 crossref_primary_10_1167_tvst_12_3_16 crossref_primary_10_1038_srep30523 crossref_primary_10_1080_13816810_2016_1217551 crossref_primary_10_1177_2515841419899495 crossref_primary_10_1007_s00417_016_3415_x crossref_primary_10_3109_13816810_2015_1120318 crossref_primary_10_1016_j_ophtha_2015_05_036 crossref_primary_10_1016_j_ophtha_2015_07_024 crossref_primary_10_1097_IIO_0000000000000336 crossref_primary_10_1002_jbm4_10741 crossref_primary_10_1167_iovs_64_13_27 crossref_primary_10_3928_23258160_20190503_11 crossref_primary_10_1371_journal_pone_0271326 crossref_primary_10_1167_iovs_63_4_7 crossref_primary_10_1016_j_exer_2022_108977 crossref_primary_10_3928_23258160_20201005_07 crossref_primary_10_1097_IAE_0000000000003122 crossref_primary_10_1016_j_oret_2025_02_018 crossref_primary_10_3928_23258160_20190401_01 crossref_primary_10_1097_IAE_0000000000000771 crossref_primary_10_1167_iovs_17_23541 crossref_primary_10_1016_j_ajo_2024_01_029 crossref_primary_10_1016_j_oret_2025_02_022 crossref_primary_10_1016_j_oret_2017_11_003 crossref_primary_10_3389_fped_2023_1252875 crossref_primary_10_1097_IJG_0000000000000810 crossref_primary_10_1186_s40942_018_0122_2 crossref_primary_10_1167_iovs_61_2_39 crossref_primary_10_1001_jamaophthalmol_2019_1484 crossref_primary_10_1016_j_survophthal_2021_01_011 crossref_primary_10_1001_jamaophthalmol_2019_1493 crossref_primary_10_1038_srep26564 crossref_primary_10_1136_bjophthalmol_2019_315598 crossref_primary_10_1136_bjophthalmol_2021_320084 crossref_primary_10_1177_24741264221129430 crossref_primary_10_1016_j_jcjo_2019_11_001 crossref_primary_10_1167_iovs_65_4_1 crossref_primary_10_22608_APO_201855 crossref_primary_10_4103_ijo_IJO_1917_20 crossref_primary_10_1371_journal_pone_0107048 crossref_primary_10_3390_genes14010212 crossref_primary_10_1097_IAE_0000000000000897 crossref_primary_10_1167_iovs_65_13_4 crossref_primary_10_3390_jcm10081767 crossref_primary_10_5301_ejo_5000639 crossref_primary_10_1097_IAE_0000000000000937 crossref_primary_10_1080_13816810_2020_1867756 crossref_primary_10_1080_13816810_2019_1686157 crossref_primary_10_1186_s12886_019_1128_8 crossref_primary_10_3390_genes12070980 crossref_primary_10_3928_23258160_20220316_04 crossref_primary_10_1080_13816810_2016_1253107 crossref_primary_10_1080_02713683_2020_1737715 crossref_primary_10_3928_23258160_20210302_07 crossref_primary_10_1080_08820538_2022_2085518 crossref_primary_10_1097_IAE_0000000000001912 crossref_primary_10_1080_02713683_2023_2213867 crossref_primary_10_1097_IIO_0000000000000260 crossref_primary_10_3928_01913913_20241122_01 crossref_primary_10_3928_23258160_20151214_02 crossref_primary_10_1016_j_exer_2023_109574 crossref_primary_10_1080_13816810_2020_1723118 crossref_primary_10_1097_IAE_0000000000004005 crossref_primary_10_1007_s00417_024_06668_7 crossref_primary_10_3928_01913913_20220228_01 crossref_primary_10_1038_eye_2015_240 crossref_primary_10_1109_ACCESS_2019_2961418 crossref_primary_10_3390_genes14030587 crossref_primary_10_3928_23258160_20210628_09 crossref_primary_10_1111_ceo_14494 crossref_primary_10_1097_IAE_0000000000003280 crossref_primary_10_1007_s10792_025_03461_1 crossref_primary_10_3928_23258160_20231020_01 crossref_primary_10_17816_rpoj112024 crossref_primary_10_3928_23258160_20220705_01 crossref_primary_10_1093_hmg_ddw041 crossref_primary_10_1016_j_ajo_2020_07_013 crossref_primary_10_1111_iwj_14611 crossref_primary_10_1016_j_ajoc_2023_101798 crossref_primary_10_1097_IAE_0000000000002623 crossref_primary_10_1007_s10384_017_0547_4 crossref_primary_10_1016_j_jaapos_2020_11_004 crossref_primary_10_3928_23258160_20180803_02 crossref_primary_10_4103_ijo_IJO_2292_21 crossref_primary_10_1155_2020_4212158 crossref_primary_10_21516_2072_0076_2023_16_3_19_25 crossref_primary_10_1097_ICB_0000000000001059 crossref_primary_10_1167_iovs_64_2_18 crossref_primary_10_1016_j_exer_2020_108165 crossref_primary_10_1002_mgg3_948 crossref_primary_10_1038_s41598_022_11455_7 crossref_primary_10_3928_23258160_20230609_01 crossref_primary_10_1016_j_preteyeres_2020_100938 crossref_primary_10_1080_13816810_2024_2427879 crossref_primary_10_1097_IAE_0000000000004147 crossref_primary_10_4274_tjo_galenos_2023_72609 crossref_primary_10_1186_s12920_022_01204_0 crossref_primary_10_1097_ICB_0000000000001322 crossref_primary_10_1167_iovs_62_15_4 crossref_primary_10_1089_crispr_2020_0009 |
Cites_doi | 10.1001/archopht.1971.01000010152007 10.1016/j.ophtha.2013.08.010 10.1111/j.1399-0004.1993.tb03898.x 10.1016/S0002-9394(14)73977-7 10.1586/eop.12.26 10.1097/IAE.0b013e3181679bf6 10.1016/S0002-9394(14)74800-7 10.1002/humu.20191 10.1002/ajmg.1320450128 10.1016/j.ophtha.2011.06.020 10.1006/bbrc.1993.1666 10.1001/archopht.1985.01050020090029 10.1016/S0161-6420(84)34119-7 10.1016/S0161-6420(98)96002-X 10.1016/0002-9394(69)91237-9 10.1001/archopht.1976.03910040034006 10.1001/archopht.1981.03930021019006 10.1167/iovs.11-8629 |
ContentType | Journal Article |
Copyright | 2014 American Academy of Ophthalmology American Academy of Ophthalmology Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2014 American Academy of Ophthalmology – notice: American Academy of Ophthalmology – notice: Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ophtha.2014.05.029 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 2227 |
ExternalDocumentID | 25005911 10_1016_j_ophtha_2014_05_029 S016164201400493X 1_s2_0_S016164201400493X |
Genre | Journal Article |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACIUM ACNCT ACRPL ACVFH ADCNI ADMUD ADNMO AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AIGII AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EFKBS EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP ADPAM RIG AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c470t-2103f765ca33078b76fbf06480c209ab5e2bc0325f61209b5e481f282068f3843 |
ISSN | 0161-6420 1549-4713 |
IngestDate | Thu Jul 10 19:16:45 EDT 2025 Mon Jul 21 06:04:19 EDT 2025 Thu Apr 24 23:03:07 EDT 2025 Tue Jul 01 03:37:57 EDT 2025 Fri Feb 23 02:22:15 EST 2024 Sun Feb 23 10:19:58 EST 2025 Tue Aug 26 16:37:04 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | FEVR familial exudative vitreoretinopathy |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c470t-2103f765ca33078b76fbf06480c209ab5e2bc0325f61209b5e481f282068f3843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25005911 |
PQID | 1629964478 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1629964478 pubmed_primary_25005911 crossref_primary_10_1016_j_ophtha_2014_05_029 crossref_citationtrail_10_1016_j_ophtha_2014_05_029 elsevier_sciencedirect_doi_10_1016_j_ophtha_2014_05_029 elsevier_clinicalkeyesjournals_1_s2_0_S016164201400493X elsevier_clinicalkey_doi_10_1016_j_ophtha_2014_05_029 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-11-01 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2014 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Bergen, Glassman (bib8) 1983; 15 Ranchod, Ho, Drenser (bib9) 2011; 118 Pendergast, Trese (bib12) 1998; 105 Poulter, Davidson, Ali (bib20) 2012; 53 Miyakubo, Hashimoto, Miyakubo (bib3) 1984; 91 Shastry, Trese (bib15) 1993; 193 Li, Fuhrmann, Schwinger (bib17) 1992; 113 Kashani, Learned, Nudleman (bib13) 2014; 121 Shastry, Trese (bib16) 1993; 45 Criswick, Schepens (bib1) 1969; 68 Li, Muller, Fuhrmann (bib18) 1992; 51 Quiram, Drenser, Lai (bib11) 2008; 28 Shastry, Hartzer, Trese (bib14) 1993; 44 Trese, Kashani (bib21) 2012; 7 Boldrey, Egbert, Gass, Friberg (bib10) 1985; 103 Qin, Hayashi, Oshima (bib22) 2005; 26 Canny, Oliver (bib2) 1976; 94 Plager, Orgel, Ellis (bib19) 1992; 114 Brockhurst, Albert, Zakov (bib6) 1981; 99 Tasman, Augsburger, Shields (bib7) 1981; 79 Gow, Oliver (bib5) 1971; 86 Benson (bib4) 1995; 93 Shastry (10.1016/j.ophtha.2014.05.029_bib16) 1993; 45 Boldrey (10.1016/j.ophtha.2014.05.029_bib10) 1985; 103 Canny (10.1016/j.ophtha.2014.05.029_bib2) 1976; 94 Li (10.1016/j.ophtha.2014.05.029_bib17) 1992; 113 Qin (10.1016/j.ophtha.2014.05.029_bib22) 2005; 26 Miyakubo (10.1016/j.ophtha.2014.05.029_bib3) 1984; 91 Kashani (10.1016/j.ophtha.2014.05.029_bib13) 2014; 121 Trese (10.1016/j.ophtha.2014.05.029_bib21) 2012; 7 Ranchod (10.1016/j.ophtha.2014.05.029_bib9) 2011; 118 Shastry (10.1016/j.ophtha.2014.05.029_bib14) 1993; 44 Brockhurst (10.1016/j.ophtha.2014.05.029_bib6) 1981; 99 Shastry (10.1016/j.ophtha.2014.05.029_bib15) 1993; 193 Gow (10.1016/j.ophtha.2014.05.029_bib5) 1971; 86 Bergen (10.1016/j.ophtha.2014.05.029_bib8) 1983; 15 Quiram (10.1016/j.ophtha.2014.05.029_bib11) 2008; 28 Plager (10.1016/j.ophtha.2014.05.029_bib19) 1992; 114 Poulter (10.1016/j.ophtha.2014.05.029_bib20) 2012; 53 Tasman (10.1016/j.ophtha.2014.05.029_bib7) 1981; 79 Pendergast (10.1016/j.ophtha.2014.05.029_bib12) 1998; 105 Li (10.1016/j.ophtha.2014.05.029_bib18) 1992; 51 Benson (10.1016/j.ophtha.2014.05.029_bib4) 1995; 93 Criswick (10.1016/j.ophtha.2014.05.029_bib1) 1969; 68 |
References_xml | – volume: 45 start-page: 111 year: 1993 end-page: 113 ident: bib16 article-title: X-linked familial exudative vitreoretinopathy (FEVR): results of DNA analysis with candidate genes publication-title: Am J Med Genet – volume: 26 start-page: 104 year: 2005 end-page: 112 ident: bib22 article-title: Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the publication-title: Hum Mutat – volume: 44 start-page: 275 year: 1993 end-page: 276 ident: bib14 article-title: Familial exudative vitreoretinopathy: multiple modes of inheritance publication-title: Clin Genet – volume: 53 start-page: 2873 year: 2012 end-page: 2879 ident: bib20 article-title: Recessive mutations in publication-title: Invest Ophthalmol Vis Sci – volume: 94 start-page: 1114 year: 1976 end-page: 1120 ident: bib2 article-title: Fluorescein angiographic findings in familial exudative vitreoretinopathy publication-title: Arch Ophthalmol – volume: 114 start-page: 145 year: 1992 end-page: 148 ident: bib19 article-title: X-linked recessive familial exudative vitreoretinopathy publication-title: Am J Ophthalmol – volume: 68 start-page: 578 year: 1969 end-page: 594 ident: bib1 article-title: Familial exudative vitreoretinopathy publication-title: Am J Ophthalmol – volume: 51 start-page: 749 year: 1992 end-page: 754 ident: bib18 article-title: The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533 publication-title: Am J Hum Genet – volume: 99 start-page: 2143 year: 1981 end-page: 2146 ident: bib6 article-title: Pathologic findings in familial exudative vitreoretinopathy publication-title: Arch Ophthalmol – volume: 103 start-page: 238 year: 1985 end-page: 241 ident: bib10 article-title: The histopathology of familial exudative vitreoretinopathy: a report of two cases publication-title: Arch Ophthalmol – volume: 93 start-page: 473 year: 1995 end-page: 521 ident: bib4 article-title: Familial exudative vitreoretinopathy publication-title: Trans Am Ophthalmol Soc – volume: 15 start-page: 275 year: 1983 end-page: 276 ident: bib8 article-title: Familial exudative vitreoretinopathy publication-title: Ann Ophthalmol – volume: 79 start-page: 211 year: 1981 end-page: 226 ident: bib7 article-title: Familial exudative vitreoretinopathy publication-title: Trans Am Ophthalmol Soc – volume: 91 start-page: 1524 year: 1984 end-page: 1530 ident: bib3 article-title: Retinal vascular pattern in familial exudative vitreoretinopathy publication-title: Ophthalmology – volume: 86 start-page: 150 year: 1971 end-page: 155 ident: bib5 article-title: Familial exudative vitreoretinopathy: an expanded view publication-title: Arch Ophthalmol – volume: 121 start-page: 262 year: 2014 end-page: 268 ident: bib13 article-title: High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy publication-title: Ophthalmology – volume: 193 start-page: 599 year: 1993 end-page: 603 ident: bib15 article-title: Mapping studies of an X-linked familial exudative vitreoretinopathy publication-title: Biochem Biophys Res Commun – volume: 7 start-page: 281 year: 2012 end-page: 292 ident: bib21 article-title: Advances in the diagnosis, management and pathophysiology of capillary nonperfusion publication-title: Expert Rev Ophthalmol – volume: 113 start-page: 712 year: 1992 end-page: 713 ident: bib17 article-title: The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11 publication-title: Am J Ophthalmol – volume: 118 start-page: 2070 year: 2011 end-page: 2075 ident: bib9 article-title: Clinical presentation of familial exudative vitreoretinopathy publication-title: Ophthalmology – volume: 28 start-page: S8 year: 2008 end-page: 12 ident: bib11 article-title: Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen) publication-title: Retina – volume: 105 start-page: 1015 year: 1998 end-page: 1023 ident: bib12 article-title: Familial exudative vitreoretinopathy. Results of surgical management publication-title: Ophthalmology – volume: 86 start-page: 150 year: 1971 ident: 10.1016/j.ophtha.2014.05.029_bib5 article-title: Familial exudative vitreoretinopathy: an expanded view publication-title: Arch Ophthalmol doi: 10.1001/archopht.1971.01000010152007 – volume: 121 start-page: 262 year: 2014 ident: 10.1016/j.ophtha.2014.05.029_bib13 article-title: High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.08.010 – volume: 15 start-page: 275 year: 1983 ident: 10.1016/j.ophtha.2014.05.029_bib8 article-title: Familial exudative vitreoretinopathy publication-title: Ann Ophthalmol – volume: 44 start-page: 275 year: 1993 ident: 10.1016/j.ophtha.2014.05.029_bib14 article-title: Familial exudative vitreoretinopathy: multiple modes of inheritance publication-title: Clin Genet doi: 10.1111/j.1399-0004.1993.tb03898.x – volume: 114 start-page: 145 year: 1992 ident: 10.1016/j.ophtha.2014.05.029_bib19 article-title: X-linked recessive familial exudative vitreoretinopathy publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)73977-7 – volume: 7 start-page: 281 year: 2012 ident: 10.1016/j.ophtha.2014.05.029_bib21 article-title: Advances in the diagnosis, management and pathophysiology of capillary nonperfusion publication-title: Expert Rev Ophthalmol doi: 10.1586/eop.12.26 – volume: 28 start-page: S8 issue: Suppl year: 2008 ident: 10.1016/j.ophtha.2014.05.029_bib11 article-title: Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen) publication-title: Retina doi: 10.1097/IAE.0b013e3181679bf6 – volume: 79 start-page: 211 year: 1981 ident: 10.1016/j.ophtha.2014.05.029_bib7 article-title: Familial exudative vitreoretinopathy publication-title: Trans Am Ophthalmol Soc – volume: 113 start-page: 712 year: 1992 ident: 10.1016/j.ophtha.2014.05.029_bib17 article-title: The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)74800-7 – volume: 26 start-page: 104 year: 2005 ident: 10.1016/j.ophtha.2014.05.029_bib22 article-title: Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes publication-title: Hum Mutat doi: 10.1002/humu.20191 – volume: 45 start-page: 111 year: 1993 ident: 10.1016/j.ophtha.2014.05.029_bib16 article-title: X-linked familial exudative vitreoretinopathy (FEVR): results of DNA analysis with candidate genes publication-title: Am J Med Genet doi: 10.1002/ajmg.1320450128 – volume: 118 start-page: 2070 year: 2011 ident: 10.1016/j.ophtha.2014.05.029_bib9 article-title: Clinical presentation of familial exudative vitreoretinopathy publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.06.020 – volume: 193 start-page: 599 year: 1993 ident: 10.1016/j.ophtha.2014.05.029_bib15 article-title: Mapping studies of an X-linked familial exudative vitreoretinopathy publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1993.1666 – volume: 51 start-page: 749 year: 1992 ident: 10.1016/j.ophtha.2014.05.029_bib18 article-title: The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533 publication-title: Am J Hum Genet – volume: 103 start-page: 238 year: 1985 ident: 10.1016/j.ophtha.2014.05.029_bib10 article-title: The histopathology of familial exudative vitreoretinopathy: a report of two cases publication-title: Arch Ophthalmol doi: 10.1001/archopht.1985.01050020090029 – volume: 91 start-page: 1524 year: 1984 ident: 10.1016/j.ophtha.2014.05.029_bib3 article-title: Retinal vascular pattern in familial exudative vitreoretinopathy publication-title: Ophthalmology doi: 10.1016/S0161-6420(84)34119-7 – volume: 105 start-page: 1015 year: 1998 ident: 10.1016/j.ophtha.2014.05.029_bib12 article-title: Familial exudative vitreoretinopathy. Results of surgical management publication-title: Ophthalmology doi: 10.1016/S0161-6420(98)96002-X – volume: 68 start-page: 578 year: 1969 ident: 10.1016/j.ophtha.2014.05.029_bib1 article-title: Familial exudative vitreoretinopathy publication-title: Am J Ophthalmol doi: 10.1016/0002-9394(69)91237-9 – volume: 93 start-page: 473 year: 1995 ident: 10.1016/j.ophtha.2014.05.029_bib4 article-title: Familial exudative vitreoretinopathy publication-title: Trans Am Ophthalmol Soc – volume: 94 start-page: 1114 year: 1976 ident: 10.1016/j.ophtha.2014.05.029_bib2 article-title: Fluorescein angiographic findings in familial exudative vitreoretinopathy publication-title: Arch Ophthalmol doi: 10.1001/archopht.1976.03910040034006 – volume: 99 start-page: 2143 year: 1981 ident: 10.1016/j.ophtha.2014.05.029_bib6 article-title: Pathologic findings in familial exudative vitreoretinopathy publication-title: Arch Ophthalmol doi: 10.1001/archopht.1981.03930021019006 – volume: 53 start-page: 2873 year: 2012 ident: 10.1016/j.ophtha.2014.05.029_bib20 article-title: Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR) publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-8629 |
SSID | ssj0006634 |
Score | 2.5108182 |
Snippet | To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the... Purpose To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2220 |
SubjectTerms | Adolescent Adult Child Child, Preschool Female Fluorescein Angiography Humans Infant Infant, Newborn Male Middle Aged Ophthalmology Optic Disk - blood supply Retinal Artery - pathology Retinal Diseases - classification Retinal Diseases - diagnosis Retinal Hemorrhage - diagnosis Retinal Telangiectasis - diagnosis Retinal Vein - pathology Retrospective Studies |
Title | Diversity of Retinal Vascular Anomalies in Patients with Familial Exudative Vitreoretinopathy |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S016164201400493X https://www.clinicalkey.es/playcontent/1-s2.0-S016164201400493X https://dx.doi.org/10.1016/j.ophtha.2014.05.029 https://www.ncbi.nlm.nih.gov/pubmed/25005911 https://www.proquest.com/docview/1629964478 |
Volume | 121 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZCmMvY_dlNzTYW3CwJd_yGNqMsNANurTLyxCSIxGXxCmJA9v-xf7xjizJdUhKu76Y2LEs-ZxP0jnH54LQpzQkmeIz4hHJ-17ISez144h6GY1g7gk5i5S2Q55-jUfn4ZdpNG21_ja8lral6GV_DsaV3IercA34qqNk_4Oz9UPhAvwG_sIROAzHO_H4pOlUcaaDl4HgF863FDT7JUjZlceVTsWfXwezVeUutK18-Gs7M6m_L_JybWIai5UuU7zzuffb1byc88XSJGyqrA620JZxvS-KXsOkMOabuSkV1R0s83V31NtT-sewHxfdSf3HsbNbD5dLXmxl7fdxsgY92zp-5Lp4yeJ3d9Br2iqC0Abt1QY0F0Sz4-OphU4P1CB_Z1E2cdMOfUFzjSX2VulOk4N7gTFLXPZWFYm0F19YJWm15NjNsv1dj0IPItCLWp9OH6AjApoHaaOjwfjsx7je3kFEswnjzahdPGblNLjf103yzk36TCXXTJ6gx1YhwQODrqeoJYtn6OGpdbl4jn7WIMMrhS3IsAMZrkGG8wI7kGENMuxAhmuQ4T2QvUDnn4eT45Fna3J4WZj4pUcCn6okjjJOYXdIRRIroUCsTf2M-H0uIklE5lMSqVhHZcN5mAaK6CoBqaJpSF-idrEq5GuEeZzMRMSzgCpQ01OVQlsikoDLfiqooB1EHeVYZhPW67opC-Y8Ey-ZoTfT9GZ-xIDeHeTVra5MwpZb7o8cU5gLRobtkwGKbmmXHGonN3Z92LCAbQjz2R6ymi2tmGvE1zv0-dGhhsEuoD_t8UKuttBXDGIlqDZJ2kGvDJzqtwclB3SoIHhzzzd9ix5dz-V3qF2ut_I9SOKl-GDnxj9T5t7P |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diversity+of+Retinal+Vascular+Anomalies+in+Patients+with+Familial+Exudative+Vitreoretinopathy&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Kashani%2C+Amir+H.&rft.au=Brown%2C+Kevin+T.&rft.au=Chang%2C+Emmanuel&rft.au=Drenser%2C+Kimberly+A.&rft.date=2014-11-01&rft.pub=Elsevier+Inc&rft.issn=0161-6420&rft.volume=121&rft.issue=11&rft.spage=2220&rft.epage=2227&rft_id=info:doi/10.1016%2Fj.ophtha.2014.05.029&rft.externalDocID=S016164201400493X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642013X00223%2Fcov150h.gif |